scienceAug 24, 20231:01:15pending
Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
About this episode
Dr Aditya Bardia from Massachusetts General Hospital in Boston, Massachusetts, and Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discuss approved and novel treatment approaches for ER-positive metastatic breast cancer that has progressed on prior CDK4/6 inhibitor therapy.
Get every episode summarized
Each time Breast Cancer Update publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Breast Cancer Update
Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and...
Breast Cancer Update
Mar 18, 202630:21failed
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Breast Cancer Update
Mar 16, 202616:43failed
Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant N...
Breast Cancer Update
Mar 2, 202658:40pending
Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San A...
Breast Cancer Update
Jan 27, 20262:01:07pending